Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-08-03

Clinical Trial Update: An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy

View source ↗

Summary

This clinical trial update assesses the development of nevirapine-induced mutations in HIV patients initiating or discontinuing combination antiretroviral thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Drug Resistance | Status: TERMINATED